Haematologica, Vol 93, Issue 3, 477-478 doi:10.3324/haematol.11952
Copyright © 2008 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lunghi, B.
Right arrow Articles by Bernardi, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lunghi, B.
Right arrow Articles by Bernardi, F.

Disorders of Hemostasis

Evaluation of factor V mRNA to define the residual factor V expression levels in severe factor V deficiency

Barbara Lunghi1, Mirko Pinotti1, Iva Maestri2, Angelika Batorova3, Francesco Bernardi1,

1 Department of Biochemistry and Molecular Biology, Ferrara University, Italy
2 Department of Experimental and Diagnostic Medicine, Section of Anatomic Pathology, Ferrara University, Italy
3 The National Hemophilia Center, Institute of Hematology and Blood Transfusion, University Hospital, Bratislava, Slovakia Funding: this work was supported by grants from Telethon Italy grant (GGP05214), the Italian Ministry of Education (MIUR), Fondazione CARIFE and funding from the University of Ferrara. Key words: FV deficiency, FV mRNA, FV mutations, hemostasis, coagulation

Correspondence: Francesco Bernardi, via Fossato di Mortara 74, I-44100, Ferrara, Italy. Phone: international +39.0532.974425. Fax: international +39.0532 974484. E-mail: ber{at}unife.it

We evaluated FV mRNA in severe factor V deficiency caused by the -12T/A IVS18 mutation, activating a cryptic splice site and leading to premature translation termination. Quantitative evaluation of factor V cDNA from homozygous and heterozygous subjects, and correction for nonsense mediated decay, suggested the presence of 0.1% of normal factor V mRNA.




This article has been cited by other articles:


Home page
 BloodHome page
C. Duckers, P. Simioni, L. Spiezia, C. Radu, P. Dabrilli, S. Gavasso, J. Rosing, and E. Castoldi
Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms
Blood, January 28, 2010; 115(4): 879 - 886.
[Abstract] [Full Text] [PDF]